Quiz|Articles|December 14, 2025

Dermatology Times Spot Test: December 14, 2025

Listen
0:00 / 0:00

Key Takeaways

  • Hidradenitis suppurativa (HS) involves chronic inflammation, painful nodules, and scarring, primarily in intertriginous areas, with significant impact on quality of life.
  • Recent research highlights genetic predispositions, immune dysregulation, and microbiome alterations as key factors in HS pathophysiology.
SHOW MORE

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Dermatology Times presents: Spot Test!

Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we'll focus on the latest news related to hidradenitis suppurativa (HS).

Do you have a set of quiz questions to share? Contact editor Marie Bosslett at mbosslett@mjhlifesciences.com to contribute!

The global prevalence of HS found in this new study is approximately equivalent to:



What type of therapeutic is NAV-240?


Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME